Results 1 to 10 of about 65 (63)
Aim. Compare the effectiveness of nebivolol and sotalol in patients with hypertensive disease (HD) and ventricular arrhythmias (VA) taking into account its effect on regulatory adaptive status (RAS). Materials and methods.
I. Z. Shubitidze +2 more
doaj +1 more source
Nebivolol i dislipidemiya u bol'nykh sakharnym diabetom 2 tipa
Цель. Оценка гипотензивных и метаболических последствий применения небиволола с NO-модулирующими свойствами у больных СД 2 типа. Материалы и методы. В рандомизированное проспективное исследование включено 35 больных СД 2 типа с мягкой артериальной не ...
Ivan Ivanovich Dedov +3 more
doaj +1 more source
Review is devoted to the role of modern beta-blocker nebivolol in the treatment of stable ischemic heart disease (IHD). The mode of nebivolol anti-ischemic activity is considered, as well as its use particularities in IHD patients with different ...
V. P. Lupanov
doaj +1 more source
RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
There were presented results of clinical trials on β-adrenoblockers usage in patients with chronic heart failure (CHF) as well as data of own study on nebivolol efficacy and tolerability in 113 patients with ischemic heart disease, complicated with CHF ...
M. L. Maximov
doaj +1 more source
THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
Aim. To study the effects of nebivolol on bone mineral density (BMD) in postmenopausal women with mild hypertension (HT) and osteopenia.Material and methods.
I. L. Tepoyan +6 more
doaj +1 more source
The potential of certain drugs to affect specific markers of progression of hypertension should be taken into account in the rational pharmacotherapy of arterial hypertension (AH) in patients with metabolic syndrome (MS).
TE Morozova +2 more
doaj +1 more source
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-
Y. V. Gavrilov +2 more
doaj +1 more source
Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods.
O. V. Fedorishina +8 more
doaj +1 more source
Цель. Оценка ангиопротективных возможности нового кардиоселективного бета-блокатора третьего поколения небиволола (небилет) с NO-модулирующей активностью у больных СД 2 типа, ассоциированного с артериальной гипертензией. Материалы и методы.
Alexander Sergeevich Ametov +2 more
doaj +1 more source
Введение. Критерии эффективности терапии желудочковых нарушений ритма сердца (ЖНРС), как правило, учитывают лишь антиаритмическое действие фармакопрепаратов, что не соответствует представлению о персонифицированном подходе в медицине.
Виталий Германович Трегубов +4 more
doaj +1 more source

